146 related articles for article (PubMed ID: 9662729)
21. Diagnostic pitfalls of ultrasonographic uterine screening in women treated with tamoxifen.
Bornstein J; Auslender R; Pascal B; Gutterman E; Isakov D; Abramovici H
J Reprod Med; 1994 Sep; 39(9):674-8. PubMed ID: 7807477
[TBL] [Abstract][Full Text] [Related]
22. The value of transvaginal ultrasonography in the endometrial evaluation of breast cancer patients using tamoxifen.
Kazerooni T; Ghaffarpasand F; Mosalaei A; Kazerooni Y
Med Princ Pract; 2010; 19(3):222-7. PubMed ID: 20357508
[TBL] [Abstract][Full Text] [Related]
23. Ultrasonography for endometrial carcinoma in postmenopausal breast cancer patients under adjuvant tamoxifen.
Cohen I; Altaras MM; Tepper R; Beyth Y
Gynecol Oncol; 1996 Dec; 63(3):412-4. PubMed ID: 8946882
[No Abstract] [Full Text] [Related]
24. The role of endovaginal ultrasonography and the value of endometrial biopsy in breast cancer patients on tamoxifen therapy.
Sivalingam N; Pathmalingam A
Singapore Med J; 1999 Jun; 40(6):402-4. PubMed ID: 10489508
[TBL] [Abstract][Full Text] [Related]
25. Uterine side effects of tamoxifen: a need for systematic pretreatment screening.
Berlière M; Charles A; Galant C; Donnez J
Obstet Gynecol; 1998 Jan; 91(1):40-4. PubMed ID: 9464718
[TBL] [Abstract][Full Text] [Related]
26. Detection of endometrial adenocarcinoma in two asymptomatic postmenopausal women receiving tamoxifen. A report of two cases.
Look K; Sanders B; Eastlund M; Sutton G
J Reprod Med; 1999 Nov; 44(11):977-80. PubMed ID: 10589411
[TBL] [Abstract][Full Text] [Related]
27. Postmenopausal endometrial pathologies with tamoxifen treatment: comparison between hysteroscopic and hysterectomy findings.
Cohen I; Azaria R; Aviram R; Bernheim J; Tepper R; Cordoba M; Beyth Y
Gynecol Obstet Invest; 1999; 48(3):187-92. PubMed ID: 10545744
[TBL] [Abstract][Full Text] [Related]
28. Indication of hysteroscopy in tamoxifen treated breast cancer patients.
Taponeco F; Curcio C; Fasciani A; Giuntini A; Artini PG; Fornaciari G; Petraglia F; Genazzani AR
J Exp Clin Cancer Res; 2002 Mar; 21(1):37-43. PubMed ID: 12071527
[TBL] [Abstract][Full Text] [Related]
29. [The use of hysterosonography and transvaginal sonography in combination with the progesterone test in asymptomatic women in risk groups in the postmenopause].
Ivanov S; Ivanov S
Akush Ginekol (Sofiia); 2000; 39 Suppl 1():6-7. PubMed ID: 10948632
[No Abstract] [Full Text] [Related]
30. Ovarian cysts in postmenopausal tamoxifen-treated breast cancer patients with endometrial thickening detected by transvaginal sonography.
Kazandi M; Sendag F; Akercan F; Terek MC; Ozsaran A; Dikmen Y
Eur J Gynaecol Oncol; 2002; 23(3):257-60. PubMed ID: 12094966
[TBL] [Abstract][Full Text] [Related]
31. Longitudinal hysteroscopic follow-up during tamoxifen treatment.
Neven P; De Muylder X; Van Belle Y; Van Hooff I; Vanderick G
Lancet; 1998 Jan; 351(9095):36. PubMed ID: 9433432
[No Abstract] [Full Text] [Related]
32. Sonohysterography for ultrasonographic evaluation of tamoxifen-associated cystic thickened endometrium.
Achiron R; Lipitz S; Sivan E; Goldenberg M; Mashiach S
J Ultrasound Med; 1995 Sep; 14(9):685-8. PubMed ID: 7500435
[TBL] [Abstract][Full Text] [Related]
33. A simple inexpensive screening test for endometrial abnormalities in asymptomatic women using tamoxifen.
Archer DF
Menopause; 2010; 17(3):454-5. PubMed ID: 20386342
[No Abstract] [Full Text] [Related]
34. Endometrial changes during tamoxifen treatment.
Ismail SM
Lancet; 1998 Mar; 351(9105):838. PubMed ID: 9519993
[No Abstract] [Full Text] [Related]
35. Surveillance for endometrial cancer in postmenopausal breast cancer patients taking tamoxifen.
Sinawat S; Chiyabutra T; Kleabkaew P
Asian Pac J Cancer Prev; 2003; 4(4):327-30. PubMed ID: 14728591
[TBL] [Abstract][Full Text] [Related]
36. Endometrial pathologies associated with postmenopausal tamoxifen treatment.
Cohen I
Gynecol Oncol; 2004 Aug; 94(2):256-66. PubMed ID: 15297160
[TBL] [Abstract][Full Text] [Related]
37. Endometrial histologic changes in post-menopausal breast cancer patients using tamoxifen.
Marchesoni D; Driul L; Fabiani G; Di Loreto C; Cataldi P; Mozzanega B
Int J Gynaecol Obstet; 2001 Dec; 75(3):257-62. PubMed ID: 11728486
[TBL] [Abstract][Full Text] [Related]
38. Dose-dependent effect of tamoxifen therapy on endometrial pathologies in postmenopausal breast cancer patients.
Cohen I; Perel E; Tepper R; Flex D; Figer A; Shapira J; Altaras MM; Fishman A; Bernheim J; Cordoba M; Yigael D; Beyth Y
Breast Cancer Res Treat; 1999 Feb; 53(3):255-62. PubMed ID: 10369071
[TBL] [Abstract][Full Text] [Related]
39. Limited value of sonohysterography for endometrial screening in asymptomatic, postmenopausal patients treated with tamoxifen.
Cohen I
Gynecol Oncol; 2001 Aug; 82(2):406-7. PubMed ID: 11531305
[No Abstract] [Full Text] [Related]
40. Comparative study of transvaginal ultrasonographic and diagnostic hysteroscopic findings in postmenopausal breast cancer patients treated with tamoxifen.
Gao WL; Zhang LP; Feng LM
Chin Med J (Engl); 2011 Aug; 124(15):2335-9. PubMed ID: 21933565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
